Found 23 matching trials
Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
PHASE4Evaluation of the safety and tolerability of a 20 mg once daily dose of mem...
Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease
PHASE4The goal of this clinical study is to evaluate satisfaction with the use of...
Alzheimer's Disease - Input of Vitamin D With mEmantine Assay
PHASE3The purpose of this study is to compare the effect after 24 weeks of the or...
Location
University Hospital
Clinical Trial to Study the Safety and Tolerability of Memantin Mepha® in Sickle Cell Disease Patients
PHASE2Symptomatic sickle cell disease is worldwide the most frequent cause for he...
Location
University Hospital Zürich
Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions
PHASE1The purpose of this study is to investigate the release of memantine into t...
Location
Shuguang Hospital, Shanghai TCM University
Corticolimbic Degeneration and Treatment of Dementia
PHASE4The overall purpose of this research is to determine if there is a relation...
Location
Multiple Locations
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
PHASE3The primary objective of this study is to examine the efficacy of memantine...
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
PHASE2Children with brain tumors who have had radiation therapy are at risk for p...
Location
St. Jude Children's Research Hospital
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
PHASE3The primary objective of the study was to examine the safety and tolerabili...
The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD
N/AThe purpose of the study is to determine the long-term safety and explorato...
Location
Samsung Medical Center